Related Experiment Videos
Mianserin: a decade of scientific development.
British Journal of Clinical Pharmacology
|January 1, 1978
Summary
Mianserin, a tetracyclic compound, was initially developed for peripheral effects but later found to be an effective antidepressant. Its unique pharmacological profile and lack of anticholinergic properties distinguish it from traditional antidepressants.
Area of Science:
- Pharmacology
- Neuroscience
- Psychiatry
Background:
- Mianserin, a tetracyclic piperazino-azepine, was synthesized in 1966.
- Initial animal screening suggested central activity but not antidepressant potential.
- Clinical observations noted sedative and mood-lifting effects.
Purpose of the Study:
- To investigate the antidepressant potential of mianserin.
- To compare the electroencephalogram (EEG) effects of mianserin with amitriptyline.
- To characterize the pharmacological and clinical profile of mianserin.
Main Methods:
- Quantitative electroencephalogram (EEG) studies.
- Clinical trials.
- Pharmacological assessments of monoamine metabolism.
Main Results:
- Mianserin demonstrated EEG effects similar to amitriptyline.
- Clinical studies confirmed mianserin as an effective antidepressant.
- Mianserin exhibits a distinct pharmacological profile, lacking anticholinergic and cardiotoxic properties.
Conclusions:
- Mianserin is an effective antidepressant with a unique profile.
- It differs from tricyclic antidepressants chemically and pharmacologically.
- Further studies presented in these proceedings elaborate on its effects.